IBDEI1RM ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30005,1,4,0)
 ;;=4^D61.9
 ;;^UTILITY(U,$J,358.3,30005,2)
 ;;=^5002342
 ;;^UTILITY(U,$J,358.3,30006,0)
 ;;=D62.^^118^1493^3
 ;;^UTILITY(U,$J,358.3,30006,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30006,1,3,0)
 ;;=3^Acute posthemorrhagic anemia
 ;;^UTILITY(U,$J,358.3,30006,1,4,0)
 ;;=4^D62.
 ;;^UTILITY(U,$J,358.3,30006,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,30007,0)
 ;;=D63.1^^118^1493^7
 ;;^UTILITY(U,$J,358.3,30007,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30007,1,3,0)
 ;;=3^Anemia in chronic kidney disease
 ;;^UTILITY(U,$J,358.3,30007,1,4,0)
 ;;=4^D63.1
 ;;^UTILITY(U,$J,358.3,30007,2)
 ;;=^332908
 ;;^UTILITY(U,$J,358.3,30008,0)
 ;;=D63.0^^118^1493^8
 ;;^UTILITY(U,$J,358.3,30008,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30008,1,3,0)
 ;;=3^Anemia in neoplastic disease
 ;;^UTILITY(U,$J,358.3,30008,1,4,0)
 ;;=4^D63.0
 ;;^UTILITY(U,$J,358.3,30008,2)
 ;;=^321978
 ;;^UTILITY(U,$J,358.3,30009,0)
 ;;=D63.8^^118^1493^9
 ;;^UTILITY(U,$J,358.3,30009,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30009,1,3,0)
 ;;=3^Anemia in other chronic diseases classified elsewhere
 ;;^UTILITY(U,$J,358.3,30009,1,4,0)
 ;;=4^D63.8
 ;;^UTILITY(U,$J,358.3,30009,2)
 ;;=^5002343
 ;;^UTILITY(U,$J,358.3,30010,0)
 ;;=D64.81^^118^1493^4
 ;;^UTILITY(U,$J,358.3,30010,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30010,1,3,0)
 ;;=3^Anemia due to antineoplastic chemotherapy
 ;;^UTILITY(U,$J,358.3,30010,1,4,0)
 ;;=4^D64.81
 ;;^UTILITY(U,$J,358.3,30010,2)
 ;;=^5002349
 ;;^UTILITY(U,$J,358.3,30011,0)
 ;;=D64.89^^118^1493^11
 ;;^UTILITY(U,$J,358.3,30011,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30011,1,3,0)
 ;;=3^Anemias NEC
 ;;^UTILITY(U,$J,358.3,30011,1,4,0)
 ;;=4^D64.89
 ;;^UTILITY(U,$J,358.3,30011,2)
 ;;=^5002350
 ;;^UTILITY(U,$J,358.3,30012,0)
 ;;=D64.9^^118^1493^10
 ;;^UTILITY(U,$J,358.3,30012,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30012,1,3,0)
 ;;=3^Anemia, unspecified
 ;;^UTILITY(U,$J,358.3,30012,1,4,0)
 ;;=4^D64.9
 ;;^UTILITY(U,$J,358.3,30012,2)
 ;;=^5002351
 ;;^UTILITY(U,$J,358.3,30013,0)
 ;;=D58.2^^118^1493^23
 ;;^UTILITY(U,$J,358.3,30013,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30013,1,3,0)
 ;;=3^Hemoglobinopathies NEC
 ;;^UTILITY(U,$J,358.3,30013,1,4,0)
 ;;=4^D58.2
 ;;^UTILITY(U,$J,358.3,30013,2)
 ;;=^87629
 ;;^UTILITY(U,$J,358.3,30014,0)
 ;;=D58.8^^118^1493^28
 ;;^UTILITY(U,$J,358.3,30014,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30014,1,3,0)
 ;;=3^Hereditary hemolytic anemias,oth specified
 ;;^UTILITY(U,$J,358.3,30014,1,4,0)
 ;;=4^D58.8
 ;;^UTILITY(U,$J,358.3,30014,2)
 ;;=^267984
 ;;^UTILITY(U,$J,358.3,30015,0)
 ;;=D59.2^^118^1493^19
 ;;^UTILITY(U,$J,358.3,30015,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30015,1,3,0)
 ;;=3^Drug-induced nonautoimmune hemolytic anemia
 ;;^UTILITY(U,$J,358.3,30015,1,4,0)
 ;;=4^D59.2
 ;;^UTILITY(U,$J,358.3,30015,2)
 ;;=^5002325
 ;;^UTILITY(U,$J,358.3,30016,0)
 ;;=Z93.0^^118^1494^9
 ;;^UTILITY(U,$J,358.3,30016,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30016,1,3,0)
 ;;=3^Tracheostomy status
 ;;^UTILITY(U,$J,358.3,30016,1,4,0)
 ;;=4^Z93.0
 ;;^UTILITY(U,$J,358.3,30016,2)
 ;;=^5063642
 ;;^UTILITY(U,$J,358.3,30017,0)
 ;;=Z93.1^^118^1494^7
 ;;^UTILITY(U,$J,358.3,30017,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30017,1,3,0)
 ;;=3^Gastrostomy status
 ;;^UTILITY(U,$J,358.3,30017,1,4,0)
 ;;=4^Z93.1
 ;;^UTILITY(U,$J,358.3,30017,2)
 ;;=^5063643
 ;;^UTILITY(U,$J,358.3,30018,0)
 ;;=Z93.2^^118^1494^8
 ;;^UTILITY(U,$J,358.3,30018,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30018,1,3,0)
 ;;=3^Ileostomy status
 ;;^UTILITY(U,$J,358.3,30018,1,4,0)
 ;;=4^Z93.2
 ;;^UTILITY(U,$J,358.3,30018,2)
 ;;=^5063644
